Clinical Accelerator
Private Company
Total funding raised: $10M
Overview
Clinical Accelerator is a lean, execution-focused CRO built to address the unique challenges of early-stage medical device trials. Founded with academic roots, the company combines deep clinical and regulatory expertise with a proven network of high-performing sites to accelerate the clinical development of breakthrough technologies. It has successfully supported over 100 MedTech clients globally, offering a flat operational structure for direct sponsor access and accountability, with a mission to turn innovative ideas into robust clinical evidence efficiently.
Technology Platform
Operational platform for early-stage medical device trials, featuring a sponsor-aligned CRO model, a dedicated site network in Eastern Europe/Central Asia, and an integrated SMPEO (Site Management, Patient Enrollment, and Operations) approach for predictable execution.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
Competes against large, full-service CROs (less agile for early studies) and other specialized device CROs. Differentiates through an exclusive FIH/EFS focus, a flat, sponsor-aligned operational model, and a strategically built site network in regions offering regulatory and recruitment advantages for early-stage trials.